Skip to main content
Log in

A Diet Containing Whey Protein, Glutamine, and TGFβ Modulates Gut Protein Metabolism During Chemotherapy-Induced Mucositis in Rats

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Mucositis, a common side effect of chemotherapy, is characterized by compromised digestive function, barrier integrity and immune competence.

Aims

Our aim was to evaluate the impact of a specifically designed diet Clinutren Protect® (CP), which contains whey proteins, TGFβ-rich casein, and free glutamine, on mucositis in rats.

Methods

Mucositis was induced by three consecutive injections (day 0, day 1, day 2) of methotrexate (2.5 mg/kg). Rats had free access to CP or placebo diets from days −7 to 9. In the placebo diet, whey proteins and TGFβ-rich casein were replaced by TGFβ-free casein and glutamine by alanine. Intestinal parameters were assessed at day 3 and 9. Values, expressed as mean ± SEM, were compared using two-way ANOVA.

Results

At day 3, villus height was markedly decreased in the placebo (296 ± 11 μm) and CP groups (360 ± 10 μm) compared with controls (464 ± 27 μm), but more markedly in the placebo as compared to CP group. The intestinal damage score was also reduced in the CP compared with the placebo group. Glutathione content increased in the CP compared with the placebo group (2.2 ± 0.2 vs. 1.7 ± 0.2 μmol/g tissue). Gut protein metabolism was more affected in the placebo than in the CP group. The fractional synthesis rate was decreased in the placebo group (93.8 ± 4.9%/day) compared with controls (121.5 ± 12.1, P < 0.05), but not in the CP group (106.0 ± 13.1). In addition, at day 9, rats exhibited improved body weight and food intake recovery in the CP compared to the placebo group.

Conclusions

Clinutren Protect® feeding reduces intestinal injury in the acute phase of methotrexate-induced mucositis in rats and improves recovery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

BCAA:

branched chain amino acids

CP:

Clinutren Protect®

FSR:

fractional synthesis rate

GSH:

glutathione

IL:

interleukin

MTX:

methotrexate

PGPH:

peptidyl glutamyl peptide hydrolysis

TGFβ:

transforming growth factor β

References

  1. Keefe DM, Gibson RJ. Mucosal injury from targeted anti-cancer therapy. Support Care Cancer. 2007;15:483–490.

    Article  PubMed  Google Scholar 

  2. Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Serum levels of nf- kappab and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther. 2008;7.

  3. Leblond J, Le Pessot F, Hubert-Buron A, et al. Chemotherapy-induced mucositis is associated with changes in proteolytic pathways. Exp Biol Med (Maywood). 2008;233:219–228.

    Article  CAS  Google Scholar 

  4. Boukhettala N, Leblond J, Claeyssens S, et al. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am J Physiol Endocrinol Metab. 2009;296:E182–E190.

    Article  CAS  PubMed  Google Scholar 

  5. Yoshizawa F. Regulation of protein synthesis by branched-chain amino acids in vivo. Biochem Biophys Res Commun. 2004;313:417–422.

    Article  CAS  PubMed  Google Scholar 

  6. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res. 1994;54:1969s–1975s.

    CAS  PubMed  Google Scholar 

  7. Sido B, Seel C, Hochlehnert A, Breitkreutz R, Droge W. Low intestinal glutamine level and low glutaminase activity in crohn’s disease. A rational for glutamine supplementation? Dig Dis Sci. 2006;51:2170–2179.

    Article  CAS  PubMed  Google Scholar 

  8. Coeffier M, Claeyssens S, Hecketsweiler B, Lavoinne A, Ducrotte P, Dechelotte P. Enteral glutamine stimulates protein synthesis and decreases ubiquitin mrna level in human gut mucosa. Am J Physiol Gastrointest Liver Physiol. 2003;285:G266–G273.

    CAS  PubMed  Google Scholar 

  9. Sukhotnik I, Khateeb K, Mogilner JG, et al. Dietary glutamine supplementation prevents mucosal injury and modulates intestinal epithelial restitution following ischemia-reperfusion injury in the rat. Dig Dis Sci. 2007;52:1497–1504.

    Article  CAS  PubMed  Google Scholar 

  10. Coeffier M, Marion R, Ducrotte P, Dechelotte P. Modulating effect of glutamine on il-1beta-induced cytokine production by human gut. Clin Nutr. 2003;22:407–413.

    Article  CAS  PubMed  Google Scholar 

  11. Xue H, Sawyer MB, Field CJ, Dieleman LA, Murray D, Baracos VE. Bolus oral glutamine protects rats against cpt-11-induced diarrhea and differentially activates cytoprotective mechanisms in host intestine but not tumour. J Nutr. 2008;138:740–746.

    CAS  PubMed  Google Scholar 

  12. Daniele B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001;48:28–33.

    Article  CAS  PubMed  Google Scholar 

  13. Braga-Neto MB, Warren CA, Oria RB, et al. Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro. Dig Dis Sci. 2008;53:2687–2696.

    Article  CAS  PubMed  Google Scholar 

  14. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99–146.

    Article  CAS  PubMed  Google Scholar 

  15. Sukhotnik I, Mogilner JG, Shaoul R, et al. Responsiveness of intestinal epithelial cell turnover to tgf-alpha after bowel resection in a rat is correlated with egf receptor expression along the villus-crypt axis. Pediatr Surg Int. 2008;24:21–28.

    Article  PubMed  Google Scholar 

  16. Fell JM, Paintin M, Donnet-Hughes A, Arnaud-Battandier F, MacDonald TT, Walker-Smith JA. Remission induced by a new specific oral polymeric diet in children with crohn’s disease. Nestle nutr workshop ser clin perform programme. 1999;2:187–196 (discussion 196–188).

  17. Beck PL, Rosenberg IM, Xavier RJ, Koh T, Wong JF, Podolsky DK. Transforming growth factor-beta mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am J Pathol. 2003;162:597–608.

    CAS  PubMed  Google Scholar 

  18. Faure M, Moennoz D, Montigon F, Mettraux C, Breuille D, Ballevre O. Dietary threonine restriction specifically reduces intestinal mucin synthesis in rats. J Nutr. 2005;135:486–491.

    CAS  PubMed  Google Scholar 

  19. Coeffier M, Claeyssens S, Lecleire S, et al. Combined enteral infusion of glutamine, carbohydrates, and antioxidants modulates gut protein metabolism in humans. Am J Clin Nutr. 2008;88:1284–1290.

    CAS  PubMed  Google Scholar 

  20. Leblond J, Hubert-Buron A, Bole-Feysot C, Ducrotte P, Dechelotte P, Coeffier M. Regulation of proteolysis by cytokines in the human intestinal epithelial cell line hct-8: role of ifngamma. Biochimie. 2006;88:759–765.

    Article  CAS  PubMed  Google Scholar 

  21. Tran CD, Howarth GS, Coyle P, Philcox JC, Rofe AM, Butler RN. Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine. Am J Clin Nutr. 2003;77:1296–1303.

    CAS  PubMed  Google Scholar 

  22. Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut. 2000;47:632–637.

    Article  CAS  PubMed  Google Scholar 

  23. Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol. 2008;62:33–41.

    Article  CAS  PubMed  Google Scholar 

  24. Carneiro-Filho BA, Lima IP, Araujo DH, et al. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci. 2004;49:65–72.

    Article  CAS  PubMed  Google Scholar 

  25. Stringer AM, Gibson RJ, Logan RM, et al. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the da rat. Exp Biol Med (Maywood). 2007;232:96–106.

    CAS  Google Scholar 

  26. Tran CD, Sundar S, Howarth GS. Dietary zinc supplementation and methotrexate-induced small intestinal mucositis in metallothionein-knockout and wild-type mice. Cancer Biol Ther 2009;8.

  27. Whitford EJ, Cummins AG, Butler RN, Prisciandaro LD, Fauser JK, Yazbeck R, Lawrence A, Cheah KY, Wright TH, Lymn KA, Howarth GS. Effects of streptococcus thermophilus th-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-fluorouracil (5-fu). Cancer Biol Ther. 2009;8.

  28. Wright TH, Yazbeck R, Lymn KA, et al. The herbal extract, iberogast, improves jejunal integrity in rats with 5-fluorouracil (5-fu)-induced mucositis. Cancer Biol Ther. 2009;8:923–929.

    PubMed  Google Scholar 

  29. Menzel K, Hausmann M, Obermeier F, et al. Cathepsins b, l and d in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clin Exp Immunol. 2006;146:169–180.

    Article  CAS  PubMed  Google Scholar 

  30. Bell-McGuinn KM, Garfall AL, Bogyo M, Hanahan D, Joyce JA. Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumour growth and invasiveness in a mouse model of multistage cancer. Cancer Res. 2007;67:7378–7385.

    Article  CAS  PubMed  Google Scholar 

  31. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002;82:373–428.

    CAS  PubMed  Google Scholar 

  32. Belmonte L, Coeffier M, Le Pessot F, et al. Effects of glutamine supplementation on gut barrier, glutathione content and acute phase response in malnourished rats during inflammatory shock. World J Gastroenterol. 2007;13:2833–2840.

    CAS  PubMed  Google Scholar 

  33. Savarese DM, Savy G, Vahdat L, Wischmeyer PE, Corey B. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev. 2003;29:501–513.

    Article  CAS  PubMed  Google Scholar 

  34. Cetiner M, Sener G, Sehirli AO, et al. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death. Toxicol Appl Pharmacol. 2005;209:39–50.

    Article  CAS  PubMed  Google Scholar 

  35. Dangin M, Boirie Y, Guillet C, Beaufrere B. Influence of the protein digestion rate on protein turnover in young and elderly subjects. J Nutr. 2002;132:3228S–3233S.

    CAS  PubMed  Google Scholar 

  36. Schaafsma G. Health issues of whey proteins. Protection of lean body mass. Curr Topics Nutraceutical Res. 2006;4:113–122.

    CAS  Google Scholar 

  37. Iyer S, Wang ZG, Akhtari M, Zhao W, Seth P. Targeting tgf beta signaling for cancer therapy. Cancer Biol Ther. 2005;4:261–266.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The skillful technical assistance of Brigitte Maurer (Laboratory of Medical Biochemistry, Rouen University Hospital) is gratefully acknowledged. We also thank Dr Richard Medeiros (Medical Editor, Rouen University Hospital) for his advice in editing the manuscript.

Conflict of Interest

PD received honoraries for lectures by Nestlé Nutrition. MF, JV and DB are employees of Nestlé. None of the other authors had a conflict of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Moïse Coëffier.

Additional information

The study was supported by Nestlé Research Center, Nutrition and Health Department, Lausanne, Switzerland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boukhettala, N., Ibrahim, A., Claeyssens, S. et al. A Diet Containing Whey Protein, Glutamine, and TGFβ Modulates Gut Protein Metabolism During Chemotherapy-Induced Mucositis in Rats. Dig Dis Sci 55, 2172–2181 (2010). https://doi.org/10.1007/s10620-009-1039-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-1039-2

Keywords

Navigation